Agil B Maharramov

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Health Promotion

Cardiovascular Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Zachary A Kipp, Genesee J Martinez, Evelyn A Bates, Agil B Maharramov, Robert M Flight, Hunter N B Moseley, Andrew J Morris, David E Stec, Terry D Hinds
Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content. Metabolites 13 (2) (2023)
Zachary A Kipp, Genesee J Martinez, Evelyn A Bates, Agil B Maharramov, Robert M Flight, Hunter N B Moseley, Andrew J Morris, David E Stec, Terry D Hinds
Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content. Metabolites 13 (2) (2023)
Zachary A Kipp, Genesee J Martinez, Evelyn A Bates, Agil B Maharramov, Robert M Flight, Hunter N B Moseley, Andrew J Morris, David E Stec, Terry D Hinds
Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content. Metabolites 13 (2) (2023)
Zachary A Kipp, Genesee J Martinez, Evelyn A Bates, Agil B Maharramov, Robert M Flight, Hunter N B Moseley, Andrew J Morris, David E Stec, Terry D Hinds
Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content. Metabolites 13 (2) (2023)
Zachary A Kipp, Genesee J Martinez, Evelyn A Bates, Agil B Maharramov, Robert M Flight, Hunter N B Moseley, Andrew J Morris, David E Stec, Terry D Hinds
Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content. Metabolites 13 (2) (2023)